Edasalonexent |
CAT-1004 |
Phase 3 Clinical |
Catabasis Pharmaceuticals Inc |
Diabetes Mellitus, Type 2; Muscular Dystrophy, Duchenne |
Details
|
NF-kappa-B decoy oligonucleotide |
MP-40; MP-41; MP-42; AMS-001; SI-3104; AMG-0101; AMG-0102; AMG-0103; S-414114 |
Phase 3 Clinical |
Anges Mg, Osaka University |
Intervertebral Disc Degeneration; Dermatitis, Atopic |
Details
|
RGN-259 |
Fx peptide; TB4 16-38; RGN-457; Thymosin beta 4-16-38; Thymosin B4; RGN-352; RGN-259; RGN-137; Tβ4; TB4; GBT-201; GBT-101; Thymosin beta4 |
Phase 3 Clinical |
National Institutes Of Health |
Keratitis; Myocardial Ischemia; ST Elevation Myocardial Infarction; Myocardial Infarction; Graft vs Host Disease; Sjogren's Syndrome; Dry Eye Syndromes; Epidermolysis Bullosa; Pressure Ulcer; Epidermolysis Bullosa, Junctional; Varicose Ulcer; Diabetes Mellitus; Epidermolysis Bullosa Dystrophica |
Details
|
Dazdotuftide |
TRS-01 |
Phase 3 Clinical |
Tarsius Pharma |
Glaucoma; Uveitis, Anterior; Uveitis; Ocular inflammation |
Details
|
Bardoxolone Methyl |
RTA-402; NSC-713200 |
Phase 3 Clinical |
Kyowa Hakko Kirin Co Ltd, Reata Pharmaceuticals Inc |
Cryptogenic Organizing Pneumonia; Melanoma; Kidney Failure, Chronic; Nephritis, Hereditary; Hamman-Rich Syndrome; Lymphoma; Renal Insufficiency, Chronic; Hepatic Insufficiency; Diabetic Nephropathies; Polycystic Kidney, Autosomal Dominant; Glomerulosclerosis, Focal Segmental; Pulmonary Arterial Hypertension; Hypertension, Pulmonary; Lung Diseases, Interstitial; Liver Diseases; Coronavirus Disease 2019 (COVID-19); Sarcoidosis; Idiopathic Pulmonary Fibrosis; Pancreatic Neoplasms; Kidney Diseases; Glomerulonephritis, IGA; Idiopathic Interstitial Pneumonias; Diabetes Mellitus, Type 2; Solid tumours |
Details
|
Hypochlorous Acid |
PR-013; PR-022 |
Phase 3 Clinical |
Realm Therapeutics |
Cataract; Virus Diseases; Coronavirus Disease 2019 (COVID-19); Endophthalmitis; Conjunctivitis, Allergic; Dermatitis, Atopic |
Details
|
Triolex |
HE-3286; NE-3107 |
Phase 3 Clinical |
Harbor Therapeutics, Biovie Inc |
Brain Injuries, Traumatic; Diabetes Mellitus, Type 2; Arthritis, Rheumatoid; Insulin Resistance; Alzheimer Disease; Colitis, Ulcerative; Parkinson Disease |
Details
|
Fluasterone |
ST002; ST001; ST-001; HE-2500; 8354; ST-002 |
Phase 2 Clinical |
Harbor |
Keratosis, Actinic; Cushing Syndrome; Metabolic Syndrome |
Details
|
Nanocurcumin (Tehran University of Medical Sciences) |
|
Phase 2 Clinical |
Tehran University Of Medical Sciences |
Neoplasms; Periapical Diseases |
Details
|
APPA |
APPA; AKL-4; AKL-IV; APPA-1 |
Phase 2 Clinical |
AKL Research & Development Ltd |
Osteoarthritis |
Details
|
CKBA |
CKBA |
Phase 2 Clinical |
BCY Pharm Co Ltd |
Psoriasis; Vitiligo; Plaque psoriasis |
Details
|
Manganese butoxyethyl pyridyl porphyrin |
BMX-001; MnTnBuOE-2-PyP5+ |
Phase 2 Clinical |
Duke University |
Head and Neck Neoplasms; Rectal Neoplasms; Glioblastoma; Astrocytoma; Carcinoma, Squamous Cell; Glioma; Brain metastases |
Details
|
CBL-0137 |
CX-137; CBL-0137; CBLC-137; Curaxin-CBL0137 |
Phase 2 Clinical |
Cleveland Biolabs Inc |
Solid tumours; Hematologic Neoplasms; Skin Melanoma; Neoplasms; Glioblastoma; Central Nervous System Neoplasms; Osteosarcoma; Sarcoma; Diffuse Intrinsic Pontine Glioma; Lymphoma; Glioma; Melanoma |
Details
|
Ornithine Phenylacetate |
OP; L-OP; OCR-002; UCL-L1V; MNK-6105; MNK-6106 |
Phase 2 Clinical |
University College London |
Liver Cirrhosis; Fibrosis; Hepatic Encephalopathy |
Details
|
Tepilamide fumarate |
PPC-06; XP-23829 |
Phase 2 Clinical |
Xenoport Inc |
Psoriasis |
Details
|
YIV-906 |
PHY-906; KD-018 |
Phase 2 Clinical |
Phytoceutica Inc |
Liver Neoplasms; Rectal Neoplasms; Pancreatic Neoplasms; Diarrhea; Hepatitis B; Colorectal Neoplasms; Carcinoma, Hepatocellular |
Details
|
GLS-1027 |
GIT-27; VGX-1027 |
Phase 2 Clinical |
Geneone Life Science Inc |
Pneumonia; Coronavirus Disease 2019 (COVID-19); Severe Acute Respiratory Syndrome |
Details
|
Dimethylaminomicheliolide Fumarate |
ACT-001 |
Phase 2 Clinical |
Tianjin Accendatech Technology Co Ltd |
Glioblastoma; Small Cell Lung Carcinoma; Ganglioglioma; Central Nervous System Neoplasms; Optic Neuritis; Neuromyelitis Optica; Breast Neoplasms; Glioma; Brain metastases; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma |
Details
|
Ascorbic Acid/Menadione |
|
Phase 2 Clinical |
Ic-Medtech Co, Summa Health System |
Joint Diseases; Prostatic Neoplasms |
Details
|
LC-280126 |
MIT-001; LC-280126; NecroX-7; LC28-0126 |
Phase 2 Clinical |
Lg Life Sciences Ltd |
Hematologic Neoplasms; ST Elevation Myocardial Infarction; Squamous Cell Carcinoma of Head and Neck; Multiple Myeloma; Lymphoma; Stomatitis |
Details
|
Ginsenoside C-K |
IH-901; Compound K |
Phase 1 Clinical |
Rohto, Il-Hwa, Zhejiang Hisun Pharmaceutical Co Ltd, Fudan University, State Pharmaceutical Administration of Shanghai Institute of Pharmaceutical Industry |
Arthritis, Rheumatoid |
Details
|
ORYN-1001 |
ORTD-1; ORYN-1001 |
Phase 1 Clinical |
Oryn Therapeutics Llc |
Coronavirus Disease 2019 (COVID-19); Arthritis, Rheumatoid |
Details
|
CKD-712 |
CKD-712 |
Phase 1 Clinical |
Chong Kun Dang Pharmaceutical Corp |
Sepsis |
Details
|
LH-025 |
LH-025 |
Phase 1 Clinical |
Dr August Wolff |
Colitis, Ulcerative |
Details
|
Xempritolimod |
KMRC-011 |
Phase 1 Clinical |
Korea Institute Of Industrial Technology |
Acute Radiation Syndrome |
Details
|
DEN-181 |
DEN-181; CurcusomeRA; CurcusomeTMRA |
Phase 1 Clinical |
Dendright |
Arthritis, Rheumatoid |
Details
|
ILB-202 |
ILB-202; ILB202 |
Phase 1 Clinical |
Ilias Biologics Inc |
Acute Kidney Injury; Intraoperative Complications |
Details
|
SFA-001 |
SFA-001; SFA-001N |
Phase 1 Clinical |
Temple University, Sfa Therapeutics |
Metabolic Dysfunction-Associated Steatotic Liver Disease; Fibrosis |
Details
|
Proximod |
|
Phase 1 Clinical |
Institue Of Materia Medica Chinese Academy Of Medical Science |
Arthritis, Rheumatoid |
Details
|
[14C]ACT-001 |
[14C]ACT001 |
Phase 1 Clinical |
Tianjin Xinyi Shangde Biomedical Technology Co Ltd |
Solid tumours |
Details
|
RHN-002 |
RHN-002; RHN002 |
Phase 1 Clinical |
RH Nanopharmaceuticals LLC |
Pain, Postoperative; Anemia, Sickle Cell |
Details
|
Hypochlorous Acid/Acetic Acid |
SS0350; SS-0350 |
Phase 1 Clinical |
Softox Solutions As |
Leg Ulcer; Varicose Ulcer |
Details
|
TLZ-16-CL |
TLZ-16-CL |
Phase 1 Clinical |
Beijing Taizhou Lize Pharmaceutical Technology Co Ltd |
Substance Withdrawal Syndrome; Cocaine-Related Disorders |
Details
|
OP-101 |
OP-101 |
Phase 1 Clinical |
Ashvattha Therapeutics |
Coronavirus Disease 2019 (COVID-19); Adrenoleukodystrophy |
Details
|
Anatabine citrate |
RCP-006 |
Clinical |
Rock Creek, Roskamp Institute |
Thyroiditis, Autoimmune; Smoking Cessation; Tobacco Use Disorder; Alzheimer Disease; Inflammation |
Details
|
Tarenflurbil spraygel (MIKA Pharma) |
|
Clinical |
Galen Ltd, Mika Pharma Gmbh |
Pain; Arthritis, Rheumatoid; Skin Diseases; Inflammation; Dermatitis, Atopic |
Details
|
RHN-001 |
RHN-001; RHN001 |
|
RH Nanopharmaceuticals LLC |
|
Details
|